Vir Biotechnology Stock Discussion

$Vir Biotechnology (VIR.US)$ The graph looks funny...

$Vir Biotechnology (VIR.US)$
Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program
Phase 3 Eclipse Program to Evaluate Tobevibart and Elebsiran

$Vir Biotechnology (VIR.US)$ Reuters· just
Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta From European Medicines Agency

$Vir Biotechnology (VIR.US)$ now you wany to sell company. But f you we have 10 dollar per share in equity and that is in cash. Cutting edge science, at least worth 10 dollar. You want to sell right now for how much? 10 dollar? I would sue you if you sell company below 20 dollar.
Firstly of first you need to pump to 20

$Vir Biotechnology (VIR.US)$ $Sanofi (SNY.US)$ Reuters· 4 mins ago
Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers

$Vir Biotechnology (VIR.US)$ Good news is my position in GILD is safe. Sick but hell if you boost price to 20, I’ll love to leave. Oncology is crowded path, bad idea.
your own platform is most valuable and made 2 Billion for the company. You just let people go…

$Vir Biotechnology (VIR.US)$ Vir Biotechnology Receives FDA Ind Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection